Mirum Pharmaceuticals, Inc.MIRMNASDAQ
Loading
Cost of Revenue Over TimeExpanding
Percentile Rank100
3Y CAGR+100.9%
5Y CAGR+176.3%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+100.9%/yr
Annual compound
5Y CAGR
+176.3%/yr
Recent deceleration
Percentile
P100
Near historical high
vs 5Y Ago
161x
Strong expansion
Streak
7 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $100.31M | +22.9% |
| 2024 | $81.64M | +73.6% |
| 2023 | $47.04M | +280.1% |
| 2022 | $12.37M | +550.2% |
| 2021 | $1.90M | +205.5% |
| 2020 | $623000.00 | +92.3% |
| 2019 | $324000.00 | - |
| 2018 | $0.00 | - |